Viewing Study NCT02805868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2026-02-27 @ 5:17 PM
Study NCT ID: NCT02805868
Status: WITHDRAWN
Last Update Posted: 2016-10-24
First Post: 2016-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Sponsor: Northwestern University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis View
None Polycythemia Vera View
None Primary Myelofibrosis View
None Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Severe View
None Anemia View
None Aplastic View
None Post-Polycythemic View
None Transformation View
None Thrombocythemia View
None Essential View